J0689
HCPCSInj cefazolin sodium, baxter
Official HCPCS Level II long descriptor
Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg
HCPCS Level II code J0689 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Inj cefazolin sodium, baxter
Added to HCPCS: 2023-01-01
Nearby codes in J0
- J0665Inj, bupivacaine, nos, 0.5mg
- J0666Inj, bupivacaine liposome
- J0668Instill, bupivac and meloxic
- J0670Inj mepivacaine hcl/10 ml
- J0675Inj, carboprost, 0.1 mg
- J0681Inj ceftobipole medocarl 3mg
- J0687Inj cefazolin (wg crit care)
- J0688Inj cefazolin sodium, hikma
- J0690Cefazolin sodium injection
- J0691Inj lefamulin 1 mg
- J0692Cefepime hcl for injection
- J0694Cefoxitin sodium injection
- J0695Inj ceftolozane tazobactam
- J0696Ceftriaxone sodium injection
- J0697Sterile cefuroxime injection
- J0698Cefotaxime sodium injection
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.